The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Flucloxacillin 125mg/5ml Oral Solution BP

125 mg/5ml Powder for oral solution

Athlone Laboratories LtdPA0298/016/003

Main Information

Trade NameFlucloxacillin 125mg/5ml Oral Solution BP
Active SubstancesFLUCLOXACILLIN SODIUM
Strength125 mg/5ml
Dosage FormPowder for oral solution
Licence HolderAthlone Laboratories Ltd
Licence NumberPA0298/016/003

Group Information

ATC CodeJ01CF Beta-lactamase resistant penicillins
J01CF05 flucloxacillin

Status

Authorised/WithdrawnAuthorised
Licence Issued14/10/2011
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0089-129-060
Interchangeable List DocumentPDF of Interchangeable List
« Back